Aβ accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model

Cited by (222)

Items 101–200 of 222

1. A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders
   Maddie Perdoncin, Alec Konrad, Joshua R. Wyner, Samir Lohana, Sneha S. Pillai, Duane G. Pereira, Hari Vishal Lakhani, Komal Sodhi · 2021 · Frontiers in Molecular Neuroscience
2. A Novel hAPP/htau Mouse Model of Alzheimer's Disease: Inclusion of APP With Tau Exacerbates Behavioral Deficits and Zinc Administration Heightens Tangle Pathology
   Stephen L. P. Lippi, Meghann L. Smith, Jane M. Flinn · 2018 · Frontiers in Aging Neuroscience
3. Berberine alleviates amyloid β25‑35‑induced inflammatory response in human neuroblastoma cells by inhibiting proinflammatory factors
   Jing Xu, Wen‐Lan Wu, Hong Zhang, Yang Li · 2018 · Experimental and Therapeutic Medicine
4. Connectivity, not region-intrinsic properties, predicts regional vulnerability to progressive tau pathology in mouse models of disease
   Christopher Mezias, Eve LoCastro, Chuying Naomi Xia, Ashish Raj · 2017 · Acta Neuropathologica Communications
5. Inhibition of an Alzheimer’s disease–associated form of necroptosis rescues neuronal death in mouse models
   Marta J. Koper, Sebastiaan Moonen, Alicja Ronisz, Simona Ospitalieri, Zsuzsanna Callaerts‐Vegh, Dries T’Syen, Sabine Rabe, Matthias Staufenbiel, Bart De Strooper, Sriram Balusu et al. · 2024 · Science Translational Medicine
6. A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation
   Deepa Ajit, Hanna Trzeciakiewicz, Jui‐Heng Tseng, Connor M. Wander, Youjun Chen, Aditi Ajit, Diamond P. King, Todd J. Cohen · 2019 · Journal of Biological Chemistry
7. In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals
   Zimmer, Eduardo Rigon, Leuzy, Antoine, Bhat, Venkat, Gauthier, Serge, Rosa-Neto, Pedro · 2014 · Translational Neurodegeneration
8. Early cognitive stimulation compensates for memory and pathological changes in Tg2576 mice
   Gorka Gereñu, Marta Dobarro, María Javier Ramírez, Francisco Javier Gil-Bea · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
9. d-ribose and pathogenesis of Alzheimer’s disease
   Mehjbeen Javed, Md. Irshad Ahmad, Hina Javed, Sufia Naseem · 2020 · Molecular Biology Reports
10. Sequence of proteome profiles in preclinical and symptomatic Alzheimer's disease
    Li, Xiaohang, Tsolis, Konstantinos C., Koper, Marta J., Ronisz, Alicja, Ospitalieri, Simona, von Arnim, Christine A.F., Vandenberghe, Rik, Tousseyn, Thomas, Scheuerle, Angelika, Economou, Anastassios et al. · 2021 · Alzheimer's & Dementia
11. A Distinct Tau Code Controlled by HDAC6 is Linked to Tau Pathogenesis and the Neuronal Stress Response
    Jui‐Heng Tseng, Aditi Ajit, Zarin Tabassum, Niyati Patel, Xu Tian, Youjun Chen, Alex W. Prevatte, Karen Ling, Frank Rigo, Rick B. Meeker et al. · 2020 · Cell Reports
12. Regulation of the Postsynaptic Compartment of Excitatory Synapses by the Actin Cytoskeleton in Health and Its Disruption in Disease
    Holly Stefen, Chanchanok Chaichim, John Power, Thomas Fath · 2016 · Neural Plasticity
13. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins
    Hasier Eraña, Vanesa Venegas, Jorge M. Charco, Joaquı́n Castilla · 2016 · Biochemical and Biophysical Research Communications
14. The effects of microglia on tauopathy progression can be quantified using Nexopathy in silico (Nexis) models
    Chaitali Anand, Pedro D. Maia, Justin Torok, Christopher Mezias, Ashish Raj · 2022 · Scientific Reports
15. Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression
    Vikas Kotari, Sudeepti S. Southekal, Michael A. Navitsky, Ian Andrew Kennedy, Ming‐Chi Lu, Amanda Morris, Jennifer A. Zimmer, Adam Fleisher, Mark A. Mintun, Michael D. Devous et al. · 2023 · Alzheimer s Research & Therapy
16. The elusive role of herpesviruses in Alzheimer’s disease: current evidence and future directions
    Stacey L. Piotrowski, Allison Tucker, Steven Jacobson · 2023 · NeuroImmune Pharmacology and Therapeutics
17. Increased Tau Phosphorylation and Tau Truncation, and Decreased Synaptophysin Levels in Mutant BRI2/Tau Transgenic Mice
    Holly J. Garringer, Jill R. Murrell, Neeraja Sammeta, Anita Gnezda, Bernardino Francesco Ghetti, Rubén Vidal · 2013 · PLoS ONE
18. Lack of exacerbation of neurodegeneration in a double transgenic mouse model of mutant LRRK2 and tau
    Fadi Mikhail, Noel Ylagan Calingasan, Luca Parolari, A. Subramanian, Liuliu Yang, M. Flint Beal · 2015 · Human Molecular Genetics
19. Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation
    Koller, Emily J., Ibanez, Kristen R., Vo, Quan, McFarland, Karen N., Gonzalez De La Cruz, Elsa, Zobel, Lillian, Williams, Tristan, Xu, Guilian, Ryu, Daniel, Patel, Preya et al. · 2022 · Neuropathology and Applied Neurobiology
20. Circadian rhythm disturbances in Alzheimer’s disease: insights from plaque-free and plaque-burdened stages in APPSWE/PS1dE9 mice
    Huijia Yang, Long Niu, Lulu Tian, Yiying Hu, Cheng Cheng, Song Li, Weidong Le · 2025 · Alzheimer s Research & Therapy
21. Spreading of Alzheimer tau seeds is enhanced by aging and template matching with limited impact of amyloid-β
    Sarah Helena Nies, Hideyuki Takahashi, Charlotte S. Herber, Anita J Huttner, Alison Chase, Stephen M. Strittmatter · 2021 · Journal of Biological Chemistry
22. The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition
    Eskandari-Sedighi, Ghazaleh, Daude, Nathalie, Gapeshina, Hristina, Sanders, David W., Kamali-Jamil, Razieh, Yang, Jing, Shi, Beipei, Wille, Holger, Ghetti, Bernardino, Diamond, Marc I. et al. · 2017 · Molecular Neurodegeneration
23. Unveiling tomorrow: Carbonic anhydrase activators and inhibitors pioneering new frontiers in Alzheimer's disease
    KM Abha Mishra, Kalyan Kumar Sethi · 2024 · Archiv der Pharmazie
24. Amyloid-Beta Pathology and Cognitive Performance in Centenarians
    Susan Karijn Rohde, Maruelle C. Luimes, Linda M.C. Lorenz, Patricia Fierro‐Hernández, Annemieke J.M. Rozemüller, Marc Hulsman, Meng Zhang, Marieke Graat, Myke E. van der Hoorn, Dominique Daatselaar et al. · 2025 · JAMA Neurology
25. Is blood pTau a reliable indicator of the CSF status? A narrative review
    Annibale Antonioni, Emanuela Maria Raho, Francesco Di Lorenzo · 2023 · Neurological Sciences
26. Characterization of a Mouse Model of Alzheimer’s Disease Expressing Aβ4-42 and Human Mutant Tau
    Zampar, Silvia, Wirths, Oliver · 2021 · International Journal of Molecular Sciences
27. Understanding the complex interplay between tau, amyloid and the network in the spatiotemporal progression of Alzheimer’s disease
    Ashish Raj, Justin Torok, Kamalini G. Ranasinghe · 2025 · Progress in Neurobiology
28. Deficiency but Not Supplementation of Selenium Impairs the Hippocampal Long-Term Potentiation and Hippocampus-Dependent Learning
    Ercan Babür, Burak Tan, Marwa Yousef, Sümeyra Cinbaş, Cem Süer, Nurcan Dursun · 2019 · Biological Trace Element Research
29. Integrating neuroinflammation biomarkers into the ATN(X) framework: Advances in Alzheimer's pathogenesis, diagnosis, and insights from non‐human primate models
    Zhihui Jin, Yan Lu, Huifang Tang, Huashun Cui · 2025 · Alzheimer s & Dementia
30. Impaired plasticity of intrinsic excitability in the dentate gyrus alters spike transfer in a mouse model of Alzheimer's disease
    Jiang, Nan, Cupolillo, Dario, Grosjean, Noelle, Muller, Emeline, Deforges, Séverine, Mulle, Christophe, Amédée, Thierry · 2021 · Neurobiology of Disease
31. Severe histomorphological alterations in post‐mortem olfactory glomeruli in Alzheimer’s disease
    Gowoon Son, Harry W.M. Steinbusch, Carmen López‐Iglesias, Cheil Moon, Ali Jahanshahi · 2021 · Brain Pathology
32. Emergence of directional bias in tau deposition from axonal transport dynamics
    Justin Torok, Pedro D. Maia, Parul Verma, Christopher Mezias, Ashish Raj · 2021 · PLoS Computational Biology
33. Advancements in research on the effects of panax notoginseng saponin constituents in ameliorating learning and memory disorders
    Shusen Liu, Min Wang, Xiao Haiyan, Jingxue Ye, Li Cao, Wenlan Li, Guibo Sun · 2024 · Heliyon
34. Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases
    Tessa Sinnige, Karen Stroobants, Christopher Martin Dobson, Michele Vendruscolo · 2020 · Quarterly Reviews of Biophysics
35. Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases – ERRATUM
    Tessa Sinnige, Karen Stroobants, Christopher Martin Dobson, Michele Vendruscolo · 2020 · Quarterly Reviews of Biophysics
36. Advances in the Study of the Pathology and Treatment of Alzheimer’s Disease and Its Association with Periodontitis
    Dan Tang, Changyun Sun, Jumei Yang, Lili Fan, Yong-Gang Wang · 2023 · Life
37. Long non‐coding RNAs as key regulators of neurodegenerative protein aggregation
    Qi Xu, Dan Liu, Ling‐Qiang Zhu, Ying Su, He‐Zhou Huang · 2025 · Alzheimer s & Dementia
38. RECENT ADVANCES IN ALZHEIMER'S DISEASE: CAUSES AND TREATMENT
    Kiranjit Kaur, Rajneet Kaur, Manjinder Kaur · 2016 · International Journal of Pharmacy and Pharmaceutical Sciences
39. Human-Induced Pluripotent Stem Cells and Herbal Small-Molecule Drugs for Treatment of Alzheimer’s Disease
    Wei Wuli, Sheng‐Tzung Tsai, Tzyy‐Wen Chiou, Horng‐Jyh Harn · 2020 · International Journal of Molecular Sciences
40. Network interdigitations of Tau and amyloid‐beta deposits define cognitive levels in aging
    Chan Mi Kim, Víctor Montal, Ibai Palacio Diez, William Orwig, Alzheimer’s Disease Neuroimaging Initiative, Jorge Sepulcre · 2021 · Human Brain Mapping
41. Asp664 cleavage of amyloid precursor protein induces tau phosphorylation by decreasing protein phosphatase 2A activity
    Seok Soon Park, Hyun‐Jung Jung, Yoon‐Jeong Kim, Tae Kwan Park, Chaeyoung Kim, Heesun Choi, In Hee Mook‐Jung, Edward H. Koo, Sun Ah Park · 2012 · Journal of Neurochemistry
42. Reduction of amyloid beta by Aβ3-10-KLH vaccine also decreases tau pathology in 3×Tg-AD mice
    Huiyi Zhang, Kun Zhu, Yuan Meng, Li Ding, Jin-Chun Wang, Wenchao Yin, Yi Yan, Yunpeng Cao · 2018 · Brain Research Bulletin
43. The Lipid Invasion Model: Growing Evidence for This New Explanation of Alzheimer’s Disease
    Jonathan D’Arcy Rudge · 2023 · Journal of Alzheimer s Disease
44. Implications of protein structure instability: From physiological to pathological secondary structure
    Alyona V. Sukhanova, Simon Poly, Anton A. Shemetov, Igor B. Bronstein, Igor R. Nabiev · 2012 · Biopolymers
45. Effects of Alzheimer’s and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer’s Disease
    Lee, Wha Jin, Yoon, Cindy W., Kim, Sung-Woo, Jeong, Hye Jin, Seo, Seongho, Na, Duk L., Noh, Young, Seong, Joon-Kyung · 2021 · Frontiers in Neuroscience
46. Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease
    Yanan Xu, Hailun Jiang, Bin Zhu, Mingnan Cao, Tao Feng, Zhongshi Sun, Guanhua Du, Zhigang Zhao · 2023 · CNS Neuroscience & Therapeutics
47. Unraveling the Potential Underlying Mechanisms of Mild Behavioral Impairment: Focusing on Amyloid and Tau Pathology
    Efthalia Angelopoulou, Anastasia M. Bougea, Alexandros Hatzimanolis, Nikolaos Scarmeas, Sokratis G. Papageorgiou · 2024 · Cells
48. Animal models for prion-like diseases
    Natalia Fernández‐Borges, Hasier Eraña, Vanesa Venegas, Saioa R. Elezgarai, Chafik Harrathi, Joaquı́n Castilla · 2015 · Virus Research
49. RETRACTED ARTICLE: Glimepiride mitigates tauopathy and neuroinflammation in P301S transgenic mice: role of AKT/GSK3β signaling
    Mennatallah O. Zaki, S. El-Desouky, Doaa A. Elsherbiny, Mohamed Salama, Samar S. Azab · 2022 · Inflammopharmacology · Retracted
50. Human microglia differentially respond to β‐amyloid, tau, and combined Alzheimer's disease pathologies in vivo
    Morgan Coburn, Ghazaleh Eskandari‐Sedighi, Jonathan Hasselmann, Whitney England, Sepideh Kiani Shabestari, Kimiya Mansour, Amanda McQuade, Michael Mgerian, Jean Paul Chadarevian, Christina H. Tu et al. · 2025 · Alzheimer s & Dementia
51. Co-aggregation of amyloidogenic proteins in age-related neurodegenerative diseases
    Shaik Basha, Prakruti Prakash Nadkarni, Aparna Ramakrishna Pai, Krishna Kishore Mahato · 2026 · Ageing Research Reviews
52. β-Amyloid induces microglial expression of GPC4 and APOE leading to increased neuronal tau pathology and toxicity
    Brandon B. Holmes, Thaddeus K. Weigel, Jesseca M. Chung, Sarah K. Kaufman, Brandon I. Apresa, James R. Byrnes, Kaan S. Kumru, Jaime Vaquer‐Alicea, Ankit Gupta, Indigo V.L. Rose et al. · 2025 · Molecular Neurodegeneration
53. Connectome-based biophysics models of Alzheimer’s disease diagnosis and prognosis
    Justin Torok, Chaitali Anand, Parul Verma, Ashish Raj · 2022 · Translational research
54. In vivo Bioluminescence Imaging Used to Monitor Disease Activity and Therapeutic Response in a Mouse Model of Tauopathy
    Ambrose A. Dunn-Meynell, Peter C. Dowling, Michelle E. Marchese, Esther Rodríguez, Benjamin M. Blumberg, Yun‐Beom Choi, Deeya Gaindh, Wei Lü · 2019 · Frontiers in Aging Neuroscience
55. Deciphering the Role of ATP on PHF6 Aggregation
    Saikat Pal, Rituparna Roy, Sandip Paul · 2022 · The Journal of Physical Chemistry B
56. Systems genetics identifies modifiers of Alzheimer’s disease risk and resilience
    Sarah M. Neuner, Timothy J. Hohman, Ryan Richholt, David Alan Bennett, Julie A. Schneider, Philip L. De Jager, Matthew J. Huentelman, Kristen M. S. O’Connell, Catherine Cook Kaczorowski · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
57. Lipoprotein Metabolism, Protein Aggregation, and Alzheimer’s Disease: A Literature Review
    Elena Grao‐Cruces, Carmen Claro, Sergio Montserrat‐de la Paz, Clévio Nóbrega · 2023 · International Journal of Molecular Sciences
58. Discrepancy of synaptic and microtubular protein phosphorylation in the hippocampus of APP/PS1 and MAPT×P301S transgenic mice at the early stage of Alzheimer’s disease
    Qiyao Wang, Chenglong Xia, An Zhu, Yongjie Bao, Jiani Lu, Yuan Chen, Jiayi Xu, Binbin Wang, C. Benjamin Naman, Liping Li et al. · 2023 · Metabolic Brain Disease
59. CD47 does not mediate amyloid-β(1–42) protofibril-stimulated microglial cytokine release
    Sanjib Karki, Michael R. Nichols · 2014 · Biochemical and Biophysical Research Communications
60. A network-level transport model of tau progression in the Alzheimer’s brain
    Veronica Tora, Justin Torok, Michiel Bertsch, Ashish Raj · 2025 · Mathematical Medicine and Biology A Journal of the IMA
61. The Adult Neurogenesis Theory of Alzheimer’s Disease
    Carlo Abbate · 2023 · Journal of Alzheimer s Disease
62. Centella asiatica, an Ayurvedic Medicinal Plant, Prevents the Major Neurodegenerative and Neurotoxic Mechanisms Associated with Cognitive Impairment
    Manuj Ahuja, Mansi Patel, Mohammed Majrashi, Vanisree Mulabagal, Muralikrishnan Dhanasekaran · 2017 · Medicinal and aromatic plants of the world
63. Importance of tau in cognitive decline as revealed by developmental exposure to lead
    Kristal Wright, Syed Waseem Bihaqi, Asma Lahouel, Anwar M. Masoud, Foqia Mushtaq, Allison Leso, A. Eid, Nasser H. Zawia · 2017 · Toxicology Letters
64. Induction of tauopathy in a mouse model of amyloidosis using intravenous administration of adeno‐associated virus vectors expressing human P301L tau
    Dylan J. Finneran, Taylor Desjarlais, Alayna Henry, Brianna M. Jackman, Marcia N. Gordon, David Morgan · 2024 · Alzheimer s & Dementia Translational Research & Clinical Interventions
65. Safety profiles of lecanemab: A systematic review and meta-analysis of randomized controlled trials and real-world evidence
    Lin Qi, Zheng Fu, Mengjiao Tu, Reema Abdullah, Yilei Zhao, Xinhui Su, Dan Zhou, Guoping Peng · 2026 · The Journal of Prevention of Alzheimer s Disease
66. Anterograde and Retrograde Propagation of Inoculated Human Tau Fibrils and Tau Oligomers in a Non-Transgenic Rat Tauopathy Model
    Lea Langer Horvat, Ena Španić, Mirjana Babić Leko, Klara Zubčić, Luka Horvat, Maja Mustapić, Patrick R. Hof, Goran Šimić · 2023 · Biomedicines
67. Single-Cell RNA Sequencing Reveals Immunomodulatory Effects of Stem Cell Factor and Granulocyte Colony-Stimulating Factor Treatment in the Brains of Aged APP/PS1 Mice
    Robert S. Gardner, Michele M. Kyle, Karen Hughes, Li‐Ru Zhao · 2024 · Biomolecules
68. Distinguishing microgliosis and tau deposition in the mouse brain using paramagnetic and diamagnetic susceptibility source separation
    Jayvik Joshi, Minmin Yao, Aaron Kakazu, Yuxiao Ouyang, Wenzhen Duan, Manisha Aggarwal · 2025 · Imaging Neuroscience
69. In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline
    Marlene F. Pereira, Reinald Shyti, G. Testa · 2024 · Stem Cell Reports
70. Searching for the cellular underpinnings of the selective vulnerability to tauopathic insults in Alzheimer’s disease
    Justin Torok, Pedro D. Maia, Chaitali Anand, Ashish Raj · 2025 · Communications Biology
71. Proteostasis and Secondary Proteinopathy in Alzheimer?s Disease
    David R. Borchelt Guilian Xu, Lucia M. Notterpek · 2014 · Journal of Alzheimer’s Disease & Parkinsonism
72. Braak Staging in Mouse Models of Alzheimer's Disease
    Ivica Granic, Marcelo F. Masman, Paul G.M. Luiten, Ulrich L.M. Eisel · 2010 · American Journal Of Pathology
73. The Determinant of Tau Spreading in Alzheimer’s Disease: Dependent on Senile Plaque, Neural Circuits, or Spatial Proximity?
    Yuichi Riku, Jean‐Pierre Brion, Kunié Ando, Toshiki Uchihara, Yasushi Iwasaki · 2025 · International Journal of Molecular Sciences
74. OXIDATIVE STRESS IN ALZHEIMER’S DISEASE–EVALUATING THE AMYLOID BETA HYPOTHESIS
    SWETHA G., Anjali Raj, SANIYA TABASSUM, Douglas Chhakchhuak · 2021 · International Journal of Current Pharmaceutical Research
75. Potential Protective Function of Aβ42 Monomer on Tauopathies
    Amber L. H. Gray, Victoria Norman, Damilola S. Oluwatoba, Rebecca A. Prosser, Thanh D. Do · 2023 · Journal of the American Society for Mass Spectrometry
76. Identification of small molecules and related targets that modulate tau pathology in a seeded primary neuron model
    Garrett S. Gibbons, Hailey Gould, Virginia M.‐Y. Lee, Alex Crowe, Kurt R. Brunden · 2023 · Journal of Biological Chemistry
77. Yi‐Zhi‐Fang‐Dai Formula Protects against Aβ1–42 Oligomer Induced Cell Damage via Increasing Hsp70 and Grp78 Expression in SH‐SY5Y Cells
    Lumei Liu, Wenbin Wan, Wenjing Chen, Yuanjin Chan, Qi Shen, Yaming Li · 2016 · Evidence-based Complementary and Alternative Medicine
78. The role of directionality in determining spatiotemporal tau pathology differs between AD-Like and Non-AD-Like mouse models
    Christopher Mezias, Ashish Raj · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
79. Directionality bias underpins divergent spatiotemporal progression of Alzheimer‐related tauopathy in mouse models
    Justin Torok, Christopher Mezias, Ashish Raj · 2025 · Alzheimer s & Dementia
80. Alzheimer’s disease pathology degrades an NMDA receptor-dependent spontaneous activity pattern in cortico-hippocampal circuits
    Robert A. Ellingford, Sam Harris, Marten Kehring, Rikesh M. Rajani, Francesca Kar Wey Lam, David R. Graykowski, Dorothea Böken, Lindsay A. Welikovitch, Anita Khasnavis, Rhiannon Laban et al. · 2026 · Neuron
81. A simple genetic stratification method for lower cost, more expedient clinical trials in early Alzheimer's disease: A preliminary study of tau PET and cognitive outcomes
    Xin Wang, Iris Broce, Yuqi Qiu, Kacie Deters, Chun Chieh Fan, Anders Martin Dale, Steven D. Edland, Sarah Jane Banks, Alzheimer’s Disease Neuroimaging Initiative · 2023 · Alzheimer s & Dementia
82. Inhibition of Tau Aggregation as a Basis for Treatment and Prevention of Alzheimer’s Disease
    Claude M. Wischik, John M. D. Storey, Damon Wischik, Charles R. Harrington · 2016 · Elsevier eBooks
83. Alzheimersche Demenz, Cholesterin und Statine: Berührungspunkte wichtiger Stoffwechselwege
    Tiago Silva, José Teixeira, Fernando Remião, Fernanda Borges · 2012 · Angewandte Chemie
84. Well-posedness of a network transport model
    Michiel Bertsch, Emilia Cozzolino, Veronica Tora · 2024 · Nonlinear Analysis
85. APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model
    Sarah Vanherle, Art Janssen, Manuel Gutiérrez de Ravé, Bieke Janssen, Chritica Lodder, Pablo Botella Lucena, Sofie Kessels, Jana Hardy, Eline Vandeput, Yanyan Wang et al. · 2025 · Molecular Psychiatry
86. Preclinical models of Alzheimer’s disease for identification and preclinical validation of therapeutic targets: from fine-tuning strategies for validated targets to new venues for therapy
    Bruno Vasconcelos, Matthew Bird, Ilie‐Cosmin Stancu, Dick Terwel, Ilse Dewachter · 2017 · Elsevier eBooks
87. Amyloid Beta
    Abhinav Anand, Neha Sharma, Monica Gulati, Navneet Khurana · 2018 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
88. Prognostic Value of A/T/N Biomarkers
    Sohyun Yim, Yuna Gu, Heekyung Kang, Daeun Shin, Hyemin Jang, Heejin Yoo, Henrik Zetterberg, Kaj Blennow, Fernando González‐Ortiz, Nicholas James Ashton et al. · 2025 · Clinical Nuclear Medicine
89. An evaluation of Roluperidone as a promising repurposing candidate for Alzheimer’s Disease: A Computational Investigation
    Rehnuma Tanjin, Md Al-Amin, Jannatul Mawa Etee, Ayesha Siddika, A.B.M. Imrul Siddiki, Saiful Islam Mahi, Sharmin Nur Toma, Nafisa Akter, Md. Helal Uddin, Neelima Akhter Bristy et al. · 2025 · PLoS ONE
90. Catalytic Effect of Amyloid-β on Native Tau Aggregation at Physiologically Relevant Concentrations
    Rakhi Chowdhury, Apu Chandra Das, Ruan van Deventer, Luda S Shlyakhtenko, Yuri L. Lyubchenko · 2025 · International Journal of Molecular Sciences
91. Targeting cholinergic cells in a mouse model of Alzheimer's disease: Validating a quadruple transgenic model
    Szidónia Farkas, Viktor Jasper, Kinga Nyers-Marosi, Bence Petrovai, Adrienn Szabó, Erika Kvak, Csenge Sólyomvári, Réka Varga, Viktória Kormos, Géza Makkai et al. · 2026 · Experimental Neurology
92. The effects of chronic cannabidiol administration on brain pathology and behavioral deficits found in the tau P301s-line PS19 mouse model of Alzheimer's disease
    Abigail G Nixon, Nancy S. Hong, Behroo Mirza Agha, Jackson R. Ham, Merrin Monteith, Tina Kaloa, Angela Kyriazopolus, Matt Nielsen, David R. Robertson, Andrey Golubov et al. · 2026 · Journal of Alzheimer s Disease
93. From pathology to precision therapy: Contemporary and emerging strategies in Alzheimer's disease treatment
    Swetha Belavadi, Sunil Kumar Kadiri · 2026 · European Journal of Pharmacology
94. Pathogenesis of neurodegenerative diseases via templated recruitment
    Jing Guo · 2013 · ScholarlyCommons (University of Pennsylvania)
95. Protein seeding in Alzheimer’s disease and Parkinson’s disease: Similarities and differences
    Tarek Ibrahim · 2014 · World Journal of Neurology
96. The Effect of Scyllo-inositol on the Neurodegeneration Induced by Alpha-synuclein Fibril Transmission in Mice
    Tarek Ibrahim · 2015 · TSpace (University of Toronto)
97. Disrupted Forward Connectivity in Parieto-temporal Network Impairs Memory Performance in Alzheimer’s Disease
    Yanin Suksangkharn, Björn Hendrik Schott, Peter Zeidman, Niklas Vockert, René Lattmann, Hartmut Schütze, Renat Yakupov, Oliver Peters, Julian Hellmann‐Regen, Lukas Preis et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
98. The Association Between Traumatic Brain Injury and Alzheimer's Disease: Mouse Models and Potential Mechanisms
    Hien Tran · 2011 · Open Scholarship Institutional Repository (Washington University in St. Louis)
99. Amyloid-β Protofibrils in Alzheimer´s Disease : Focus on Antibodies, Inflammation and Astrocytes
    Sofia Söllvander · 2015 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
100. Potential Treatments for Alzheimer’s Disease
     A. A. Farooqui · 2017 · Elsevier eBooks